ANI Pharmaceuticals, Inc. (ANIP) Operating income 2016–2025
ANI Pharmaceuticals, Inc. (ANIP) annual operating income history from SEC filings — each fiscal year as reported.
$111.1MFY2025 · since FY2016: $20.1M → $111.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $111.1M | +18922.8% |
| FY2024 | $584,000 | -98.8% |
| FY2023 | $47.0M | +233.1% |
| FY2022 | -$35.3M | +11.3% |
| FY2021 | -$39.8M | -148.5% |
| FY2020 | -$16.0M | -198.0% |
| FY2019 | $16.4M | -53.8% |
| FY2018 | $35.4M | +24.8% |
| FY2017 | $28.3M | +41.1% |
| FY2016 | $20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice